Matches in Wikidata for { <http://www.wikidata.org/entity/Q93022176> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q93022176 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93022176 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93022176 description "scientific article published on 22 June 2019" @default.
- Q93022176 description "wetenschappelijk artikel" @default.
- Q93022176 description "наукова стаття, опублікована 22 червня 2019" @default.
- Q93022176 name "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 name "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 type Item @default.
- Q93022176 label "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 label "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 prefLabel "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 prefLabel "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 P1433 Q93022176-126944A1-8414-44B1-8691-19EBE656D166 @default.
- Q93022176 P1476 Q93022176-1D900D18-B1C9-48F6-9525-BF03AF1E73B8 @default.
- Q93022176 P2093 Q93022176-0509E195-6FD8-408A-B318-615B53AB0252 @default.
- Q93022176 P2093 Q93022176-114C46DA-780E-4691-BC7A-605CE15BA38F @default.
- Q93022176 P2093 Q93022176-B9B6CF28-61F4-4E56-8936-8D7E5DFF04E3 @default.
- Q93022176 P304 Q93022176-BAC13C14-CA63-4A18-AF87-C89087936DD6 @default.
- Q93022176 P31 Q93022176-C6635D76-9180-41CE-AD9A-161CD163C308 @default.
- Q93022176 P356 Q93022176-506CC57B-E60C-44CA-9B35-2C7D66369527 @default.
- Q93022176 P433 Q93022176-69D46B6A-202A-4402-B6AC-3593C26A72D9 @default.
- Q93022176 P478 Q93022176-F249C6F8-B44D-4E58-BCAB-465658200CFD @default.
- Q93022176 P50 Q93022176-FB5491FB-B85E-49A9-B883-A18D06D27D61 @default.
- Q93022176 P577 Q93022176-EFD5A9E1-0F66-4F7C-A39A-2942F27D39A9 @default.
- Q93022176 P698 Q93022176-B67D6EDA-5B58-4F12-B27A-AC14CA5B95A3 @default.
- Q93022176 P921 Q93022176-9D580AEF-97FB-45E6-95D4-0A0A7FB5730B @default.
- Q93022176 P356 J.JIAC.2019.05.032 @default.
- Q93022176 P698 31239195 @default.
- Q93022176 P1433 Q15756830 @default.
- Q93022176 P1476 "Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients" @default.
- Q93022176 P2093 "Junichi Kawakami" @default.
- Q93022176 P2093 "Takahiro Yamada" @default.
- Q93022176 P2093 "Yasuaki Mino" @default.
- Q93022176 P304 "1019-1025" @default.
- Q93022176 P31 Q13442814 @default.
- Q93022176 P356 "10.1016/J.JIAC.2019.05.032" @default.
- Q93022176 P433 "12" @default.
- Q93022176 P478 "25" @default.
- Q93022176 P50 Q57148689 @default.
- Q93022176 P577 "2019-06-22T00:00:00Z" @default.
- Q93022176 P698 "31239195" @default.
- Q93022176 P921 Q412236 @default.